RameshKRamanathanMD

Oncology • Scottsdale, AZ

Physician

Join to view full profile

Dr. Ramanathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ramanathan's full profile

Already have an account?

Office
8880 E Desert Cove Ave
Scottsdale, AZ 85260
Phone+1 480-314-6670

Fax+1 480-257-1997

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1993 - 1995
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1988 - 1991
Karnataka Institute of Medical ScienceClass of 1986

Certifications & Licensure

AZ State Medical License 2007 - 2026
CA State Medical License 1993 - 2025
FL State Medical License 1999 - 2025
IN State Medical License 2003 - 2017
WI State Medical License 1987 - 2017
IL State Medical License 1989 - 2014
PA State Medical License 1991 - 2012
NY State Medical License 1991 - 1992
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013

Clinical Trials

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer Start of enrollment: 1998 Nov 01
Completed
Phase 1
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 1998 Oct 01
Completed
Phase 3
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 Start of enrollment: 1999 Sep 01
Completed
Phase 2
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 1996 Jan 01
Completed
Phase 1
Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 1998 May 01
Completed
Phase 1
Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors Start of enrollment: 1998 Jun 01
Completed
Phase 1
Safety Study of S-CKD602 in Patients With Advanced Malignancies Start of enrollment: 2003 Sep 01
Completed
Phase 1
Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors Start of enrollment: 2008 Jan 01
Terminated
Phase 1
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors Start of enrollment: 2010 Jul 01
Completed
Phase 1
A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients Start of enrollment: 2010 Dec 01
Completed
Phase 1, Phase 2
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors Start of enrollment: 2011 Jan 03
Completed
Phase 1
Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer Start of enrollment: 2011 May 01
Completed
Phase 2
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Jan 01
Completed
Phase 1
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer Start of enrollment: 2011 Nov 01
Completed
Phase 1, Phase 2
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA Start of enrollment: 2013 May 01
Completed
Phase 1, Phase 2
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma Start of enrollment: 2013 Nov 01
Terminated
Phase 1
Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors Start of enrollment: 2013 Oct 01
Completed
Phase 1
BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients Start of enrollment: 2016 Jul 06
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

298 citations
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed Kaseb, Gauri R. Varadhachary
JAMA Oncology. 2019-06-01
229 citations
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Jae W. Lee, Meredith L. Stone, Paige M. Porrett, Stacy K. Thomas, Chad A. Komar
Nature. 2019-03-06
4433 citations
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante
The New England Journal of Medicine. 2013-10-30

Journal Articles

Targeting the Stroma in Pancreatic Cancer
Daniel H Ahn, Ramesh K Ramanathan, Annals of Palliative Medicine

Press Mentions

Biological Breakthroughs in Pancreas CancerOctober 10th, 2017
Expert Hopes Novel Approaches Improve Outlook in Pancreatic CancerMarch 7th, 2017
Shop TalkOctober 10th, 2014
Join now to see all

Grant Support

Rndm Ph2 NON Compare Of SB-715992 Wkly Or Evry 3 WKS In Metastatic Col CancerNational Center For Research Resources2005
Ph1 Pharmco Stdy ST1571 PTS W/Adv Malig Levels Liver DysfunctionNational Center For Research Resources2005
Ph1 Pharmaco Epothilone B Analogue BMS-247550 Adv Malign LiverNational Center For Research Resources2005
Ph1 Pharm PS341 In PTS W/Adv Malign Varying Degrees Renal Dysf CtepNational Center For Research Resources2005
Ph1 (17-Dmag) In PTS W/Adv Solid TumorsNational Center For Research Resources2005
A Phase I Trial Of Weekly 17-Allyamino-17 Demethoxygeldanamycin (17AAG)National Center For Research Resources2005
A Ph1b Stdy MUCI Pulsed Dendritic Cell Vaccine In PTS W/Resected PancreaticNational Center For Research Resources2005
PHI Study Wkly Docetaxel In Combo W/CapecitabineNational Center For Research Resources2004
Ph2 Trial Rebeccamycin In Hepatobiliary CancerNational Center For Research Resources2004
Ph1 Pharmco Stdy ST1571 PTS W/Adv Malig. Liver DisorderNational Center For Research Resources2004
PH I Pharmacokinetics Stdy ST1571 In Advanced MalignancyNational Center For Research Resources2004
A Phase I Trial Of Weekly 17AAGNational Center For Research Resources2004
Herceptin, Gemcitabine For Metastatic Pancreatic CancerNational Center For Research Resources2000–2002
Gadolinium Texaphyrin Radiotherapy In Biliary/Pancreas CNational Center For Research Resources2000–2002
9 Nitro Camptothecin In Advanced Colorectal CancerNational Center For Research Resources2000–2002
Dose Escalation Trial Of 100aa Synthetic Mucin Peptide Pancreatic CancerNational Center For Research Resources1999–2002
Phase I Dose Escalation Trial Of Synthetic Mucin Peptide On Pancreatic CancerNational Center For Research Resources1999